UBS Group’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,769
| Closed | -$1.19K | – | 11488 |
|
|
2022
Q4 | $1.19K | Sell |
2,769
-677
| -20% | -$341 | ﹤0.01% | 9927 |
|
|
2022
Q3 | $2K | Sell |
3,446
-6,408
| -65% | -$4.81K | ﹤0.01% | 9878 |
|
|
2022
Q2 | $6K | Buy |
9,854
+9,853
| +985,300% | +$8.38K | ﹤0.01% | 8802 |
|
|
2022
Q1 | $0 | Sell |
1
-5,590
| -100% | -$5.6K | ﹤0.01% | 11342 |
|
|
2021
Q4 | $6K | Buy |
5,591
+2,622
| +88% | +$4.81K | ﹤0.01% | 9337 |
|
|
2021
Q3 | $7K | Sell |
2,969
-6,526
| -69% | -$16.4K | ﹤0.01% | 8366 |
|
|
2021
Q2 | $28K | Sell |
9,495
-15,618
| -62% | -$43.9K | ﹤0.01% | 7015 |
|
|
2021
Q1 | $77K | Buy |
25,113
+22,835
| +1,002% | +$83.9K | ﹤0.01% | 6167 |
|
|
2020
Q4 | $11K | Sell |
2,278
-1,272
| -36% | -$6.4K | ﹤0.01% | 7445 |
|
|
2020
Q3 | $18K | Sell |
3,550
-35
| -1% | -$202 | ﹤0.01% | 6414 |
|
|
2020
Q2 | $20K | Buy |
3,585
+2,871
| +402% | +$18K | ﹤0.01% | 6574 |
|
|
2020
Q1 | $5K | Buy |
714
+110
| +18% | +$1.09K | ﹤0.01% | 7342 |
|
|
2019
Q4 | $7K | Buy |
604
+584
| +2,920% | +$16.6K | ﹤0.01% | 7479 |
|
|
2019
Q3 | $1K | Sell |
20
-11
| -35% | -$1.98K | ﹤0.01% | 7880 |
|
|
2019
Q2 | $12K | Sell |
31
-2,332
| -99% | -$1.26M | ﹤0.01% | 6971 |
|
|
2019
Q1 | $2.22M | Hold |
2,363
| – | – | ﹤0.01% | 2903 |
|
|
2018
Q4 | $2.48M | Buy |
+2,363
| New | +$5.67M | ﹤0.01% | 2833 |
|
|
2018
Q3 | – | Sell |
-7
| Closed | -$19K | – | 8383 |
|
|
2018
Q2 | $19K | Buy |
+7
| New | +$20.2K | ﹤0.01% | 6746 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 8286 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$10.4K | – | 7745 |
|
|
2017
Q3 | $11K | Buy |
+2
| New | +$12.3K | ﹤0.01% | 6850 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7540 |
|
|
2017
Q1 | – | Sell |
-3
| Closed | -$16K | – | 8108 |
|
|
2016
Q4 | $16K | Buy |
3
+2
| +200% | +$11.9K | ﹤0.01% | 6657 |
|
|
2016
Q3 | $4K | Buy |
+1
| New | +$6.64K | ﹤0.01% | 7224 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 8059 |
|
Other funds holding VIVE
UBS Group's VIVE Position: Q1 2023 in Review
UBS Group sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 2,769 shares — an estimated $1.19K sold.
UBS Group first reported a position in VIVE in Q3 2016 and held it in 21 quarters. The position peaked at $2.48M in Q4 2018. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- UBS Group reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- UBS Group sold 2,769 VIVEVE MED INC shares in Q1 2023, an estimated $1.19K.
- UBS Group first reported a position in VIVEVE MED INC in Q3 2016 and held it in 21 quarters.
- UBS Group's VIVEVE MED INC position peaked at $2.48M in Q4 2018.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.